Details

Autor(en) / Beteiligte

• Cornejo-Pareja, Isabel
• Martín-Núñez, Gracia M
• Roca-Rodríguez, M Mar
• Cardona, Fernando
• Coin-Aragüez, Leticia
• Sánchez-Alcoholado, Lidia
• Gutiérrez-Repiso, Carolina
• Muñoz-Garach, Araceli
• Fernández-García, José C
• Moreno-Indias, Isabel
• Tinahones, Francisco J

Titel

H. pylori Eradication Treatment Alters Gut Microbiota and GLP-1 Secretion in Humans

Ist Teil von

• Journal of clinical medicine, 2019-04, Vol.8 (4), p.451

Ort / Verlag

Switzerland: MDPI

Erscheinungsjahr

2019

Link zum Volltext

Quelle

EZB Free E-Journals

Beschreibungen/Notizen

• Changes in the intestinal microbial community and some metabolic disturbances, including obesity and type2 diabetes, are related. Glucagon-like peptide-1 (GLP-1) regulates glucose homeostasis. Microbiota have been linked to incretin secretion. Antibiotic use causes changes in microbial diversity and composition. Our aim was to evaluate the relationship between microbiota changes and GLP-1 secretion. A prospective case-control study with a -positive patient model involving subjects under eradication therapy (omeprazole, clarithromycin, and amoxicillin). Forty patients with infection and 20 matched participants, but negative for antigen. Patients were evaluated before and two months after treatment. We analyzed anthropometric measurements, carbohydrate metabolism, lipid profile, and C-reactive protein. Gut microbiota composition was analyzed through 16S rRNA amplicon sequencing (IlluminaMiSeq). Eradication treatment for decreased bacterial richness (Chao1, 0.041). Changes in gut microbiota profiles were observed at phylum, family, genus and species levels. GLP-1 secretion and variables of carbohydrate metabolism were improved. Correlations were seen between GLP-1 changes and variations within microbial community abundances, specifically , the genus, and family. A conventional treatment to eradicate could improve carbohydrate metabolism possibly in relation with an increase in GLP-1 secretion. GLP-1 secretion may be related to alterations in intestinal microbiota, specifically and .